Risk of small intestinal bacterial overgrowth in patients receiving proton pump inhibitors versus proton pump inhibitors plus prokinetics.

Pruthvi C RevaiahRakesh KochharSurinder V RanaNeha BerryMunish AshatNarendra DhakaY Rami ReddySaroj Kant Sinha

Published in: JGH open : an open access journal of gastroenterology and hepatology (2018)

The use of prokinetics in patients on PPI may reduce the risk of SIBO by enhancing intestinal motility and may reduce SIBO risk associated with long-term PPI use.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
prognostic factors
peritoneal dialysis
escherichia coli
patient reported outcomes
cystic fibrosis